Cagrilintide vs AOD 9604 Mechanism: Cagrilintide: Amylin receptor agonist (appetite/satiety) AOD 9604: HGH fragment (fat metabolism) Completely different Weight loss: Cagrilintide: 10-12% body weight AOD 9604: 5-8% body weight (less robust data) Cagrilintide superior Clinical evidence: Cagrilintide: Extensive Phase 2/3 trials AOD 9604: Limited clinical data Cagrilintide better studied Side effects: Cagrilintide: GI effects common AOD 9604: Minimal side effects AOD 9604 better tolerated Combination potential: Could theoretically combine (different mechanisms) No clinical data on combination Cagrilintide + semaglutide better established Verdict: Cagrilintide more powerful, better evidence
Liu H, Harrell LE, Shenvi S, Hagen T, Liu RM
Its key research differentiator is selectivity preclinical data shows GH release without significant elevation of cortisol, prolactin, or ACTH, unlike GHRP-2 and GHRP-6
Additionally, fucoidan may stimulate dendritic cell maturation via TNF-dependent pathways, strengthening host immunity
doi: 10.18502/jri.v24i2.12491
Other nutrients that might be added include: magnesium, taurine, and B-complex vitamins